Genesee Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,709
| Closed | -$1.79M | – | 84 |
|
|
2022
Q3 | $1.79M | Sell |
21,709
-647
| -3% | -$53.5K | 1.37% | 16 |
|
|
2022
Q2 | $2.13M | Sell |
22,356
-2,890
| -11% | -$275K | 1.49% | 16 |
|
|
2022
Q1 | $2.97M | Sell |
25,246
-364
| -1% | -$42.9K | 1.55% | 15 |
|
|
2021
Q4 | $3.32M | Sell |
25,610
-636
| -2% | -$82.4K | 1.58% | 15 |
|
|
2021
Q3 | $2.97M | Buy |
+26,246
| New | +$2.97M | 1.47% | 18 |
|
|
2021
Q2 | – | Sell |
-26,860
| Closed | -$2.25M | – | 69 |
|
|
2021
Q1 | $2.25M | Buy |
26,860
+3,145
| +13% | +$263K | 1.33% | 21 |
|
|
2020
Q4 | $2.16M | Buy |
23,715
+33
| +0.1% | +$3.01K | 1.42% | 24 |
|
|
2020
Q3 | $1.89M | Sell |
23,682
-326
| -1% | -$26K | 1.56% | 19 |
|
|
2020
Q2 | $1.66M | Sell |
24,008
-3,862
| -14% | -$267K | 1.54% | 22 |
|
|
2020
Q1 | $1.75M | Sell |
27,870
-8,634
| -24% | -$543K | 1.68% | 15 |
|
|
2019
Q4 | $2.84M | Sell |
36,504
-786
| -2% | -$61.1K | 2.42% | 7 |
|
|
2019
Q3 | $2.73M | Sell |
37,290
-99
| -0.3% | -$7.26K | 2.53% | 7 |
|
|
2019
Q2 | $2.3M | Sell |
37,389
-1,368
| -4% | -$84.2K | 2.32% | 9 |
|
|
2019
Q1 | $2.47M | Buy |
38,757
+2,202
| +6% | +$140K | 2.97% | 7 |
|
|
2018
Q4 | $1.87M | Buy |
+36,555
| New | +$1.87M | 3.05% | 7 |
|